Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Edward Dempsey

Concepts (333)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neprilysin
6
2017
47
2.420
Why?
Muscle, Smooth, Vascular
22
2017
411
2.330
Why?
Pulmonary Artery
26
2020
1015
1.830
Why?
Protein Kinase C
15
2007
273
1.800
Why?
Hypoxia
18
2021
957
1.350
Why?
rho GTP-Binding Proteins
2
2020
61
1.230
Why?
Pulmonary Circulation
7
2009
407
0.980
Why?
Isoenzymes
9
2007
283
0.730
Why?
Hypertension, Pulmonary
12
2021
1728
0.730
Why?
Lung
11
2021
3559
0.700
Why?
Evans Blue
1
2018
6
0.630
Why?
Capillary Permeability
1
2018
139
0.600
Why?
Cell Division
25
2009
758
0.570
Why?
Protein Kinase C-epsilon
3
2005
27
0.560
Why?
Myocytes, Smooth Muscle
2
2019
235
0.550
Why?
Muscle Proteins
1
2017
210
0.520
Why?
Blood Vessels
3
2016
180
0.500
Why?
Endothelium, Vascular
2
2020
847
0.440
Why?
Aging
4
2020
1618
0.440
Why?
Animals
44
2021
31698
0.430
Why?
Mice, Knockout
6
2017
2568
0.430
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
25
0.420
Why?
Animals, Newborn
10
2007
778
0.380
Why?
Airway Remodeling
1
2010
57
0.350
Why?
Pulmonary Disease, Chronic Obstructive
3
2017
913
0.340
Why?
Cattle
16
2002
921
0.300
Why?
Mice
14
2018
14863
0.290
Why?
Fibroblasts
7
2019
838
0.290
Why?
Endothelin-1
2
2017
167
0.250
Why?
Signal Transduction
7
2020
4512
0.240
Why?
Protein Kinases
1
2007
307
0.240
Why?
Lung Neoplasms
11
2012
2177
0.240
Why?
Enzyme Activation
5
2017
785
0.220
Why?
rho-Associated Kinases
2
2019
80
0.220
Why?
Cells, Cultured
12
2017
3885
0.210
Why?
Mice, Inbred C57BL
5
2017
4692
0.210
Why?
Lung Diseases
2
2007
701
0.210
Why?
Vascular Remodeling
2
2021
153
0.210
Why?
Insulin-Like Growth Factor I
3
1997
286
0.210
Why?
Potassium Channels, Voltage-Gated
1
2002
48
0.210
Why?
Vascular Endothelial Growth Factor Receptor-2
3
2012
86
0.200
Why?
Cell Movement
3
2017
868
0.190
Why?
Vasoconstriction
1
2002
177
0.190
Why?
Growth Substances
4
1997
138
0.190
Why?
Tetradecanoylphorbol Acetate
5
1997
153
0.190
Why?
Butyrates
1
2021
53
0.180
Why?
Proto-Oncogene Proteins c-myc
2
2020
115
0.180
Why?
Phenotype
5
2017
2796
0.180
Why?
Metabolic Diseases
1
2021
98
0.180
Why?
Mitogens
2
1997
58
0.170
Why?
Forkhead Box Protein O3
1
2020
13
0.170
Why?
Receptors, G-Protein-Coupled
1
2021
194
0.170
Why?
Platelet-Derived Growth Factor
3
1997
82
0.170
Why?
Vasa Vasorum
1
2020
33
0.170
Why?
JNK Mitogen-Activated Protein Kinases
1
2020
144
0.170
Why?
rhoA GTP-Binding Protein
1
2019
73
0.160
Why?
Genotype
2
2017
1760
0.160
Why?
Cellular Microenvironment
1
2019
78
0.160
Why?
Metabolome
1
2021
282
0.160
Why?
Pulmonary Alveoli
2
2012
373
0.160
Why?
Thymidine
5
1996
58
0.150
Why?
ets-Domain Protein Elk-1
1
2017
13
0.150
Why?
Smooth Muscle Myosins
1
2017
7
0.150
Why?
Kruppel-Like Transcription Factors
1
2017
61
0.140
Why?
Actins
3
2017
381
0.140
Why?
Microfilament Proteins
1
2017
126
0.140
Why?
Vascular Diseases
1
2019
230
0.130
Why?
Calcium-Binding Proteins
1
2017
206
0.130
Why?
Chronic Disease
6
2009
1578
0.130
Why?
Substance P
1
2016
44
0.130
Why?
Doxycycline
1
2016
55
0.130
Why?
Pneumonia
1
2021
567
0.130
Why?
Duodenum
1
2016
62
0.130
Why?
Neovascularization, Pathologic
5
2020
281
0.130
Why?
Sleep Apnea Syndromes
2
2013
74
0.120
Why?
Uterus
3
2006
192
0.120
Why?
Humans
30
2021
114654
0.120
Why?
Carcinogens
2
2012
103
0.120
Why?
Myocardium
1
2019
913
0.120
Why?
In Vitro Techniques
5
2007
1016
0.120
Why?
Cell Communication
1
1996
279
0.120
Why?
Sputum
3
2005
285
0.110
Why?
Endothelial Cells
3
2021
685
0.110
Why?
Estradiol
2
1997
455
0.110
Why?
Enzyme Inhibitors
4
2002
750
0.110
Why?
Cell Proliferation
2
2017
2186
0.100
Why?
Gene Expression Regulation, Developmental
1
1997
800
0.100
Why?
Piperidines
2
2012
160
0.100
Why?
Blotting, Western
3
2012
1147
0.100
Why?
Quinazolines
2
2012
240
0.100
Why?
Gene Expression Regulation
3
2016
2319
0.100
Why?
Mice, Transgenic
1
2016
1947
0.090
Why?
Gene Expression Regulation, Enzymologic
2
2005
270
0.090
Why?
Bronchoscopy
5
2009
245
0.090
Why?
DNA Primers
2
2009
510
0.090
Why?
Somatomedins
1
1990
28
0.090
Why?
Cardiovascular Diseases
1
2021
1727
0.090
Why?
Arteries
2
2006
247
0.090
Why?
Carcinoma in Situ
3
2005
44
0.090
Why?
Precancerous Conditions
3
2004
158
0.090
Why?
Maleimides
3
2000
24
0.080
Why?
Biomarkers
1
2020
3408
0.080
Why?
Blood Pressure
3
2021
1538
0.080
Why?
Isotretinoin
1
2009
22
0.080
Why?
Tocopherols
1
2009
22
0.080
Why?
ErbB Receptors
1
2012
554
0.080
Why?
Cell Hypoxia
3
1999
220
0.080
Why?
Female
17
2012
59488
0.080
Why?
Biomarkers, Tumor
3
2012
1040
0.080
Why?
Carcinoma, Squamous Cell
2
2005
577
0.070
Why?
Male
10
2018
55579
0.070
Why?
Indoles
3
2000
304
0.070
Why?
Bronchi
2
2000
231
0.070
Why?
Galectin 1
1
2006
2
0.070
Why?
Heart Failure
1
2019
1945
0.070
Why?
Genes, ras
2
1997
91
0.070
Why?
Hyperoxia
1
2007
99
0.070
Why?
Videotape Recording
1
2006
30
0.070
Why?
Rats, Sprague-Dawley
3
2021
2218
0.060
Why?
Disease Models, Animal
2
2013
3531
0.060
Why?
Thiazolidinediones
1
2006
142
0.060
Why?
Smoking
4
2009
1381
0.060
Why?
Hypertrophy, Right Ventricular
2
2021
141
0.060
Why?
Rats
4
2021
4958
0.060
Why?
DNA
4
1997
1352
0.060
Why?
Nitric Oxide Synthase Type II
1
2005
157
0.060
Why?
Blood
2
1995
96
0.060
Why?
Nitric Oxide Synthase Type III
1
2005
184
0.060
Why?
Calcium
2
2002
1108
0.060
Why?
Endothelins
2
1996
61
0.060
Why?
Drug Synergism
3
1996
316
0.060
Why?
Drug Delivery Systems
1
2007
296
0.060
Why?
Hemodynamics
1
2009
1012
0.060
Why?
Bronchoalveolar Lavage Fluid
2
1997
590
0.060
Why?
Guinea Pigs
3
2006
136
0.060
Why?
Case-Control Studies
1
2010
3003
0.050
Why?
Fetus
2
1997
700
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2005
386
0.050
Why?
Shaw Potassium Channels
1
2002
4
0.050
Why?
Stem Cells
1
2007
545
0.050
Why?
Potassium Chloride
1
2002
32
0.050
Why?
Potassium Channel Blockers
1
2002
29
0.050
Why?
Angiotensin II
1
2002
87
0.050
Why?
Potassium Channels
1
2002
121
0.050
Why?
Nitric Oxide Synthase
1
2002
209
0.050
Why?
Antineoplastic Agents
2
2010
1879
0.050
Why?
Tunica Media
2
1998
35
0.050
Why?
Urethane
2
2012
41
0.050
Why?
Protein Kinase C beta
2
2000
24
0.050
Why?
Macrophages
2
2021
1261
0.050
Why?
Patient Education as Topic
1
2006
680
0.050
Why?
Aged
6
2010
19068
0.050
Why?
Gene Deletion
1
2002
356
0.050
Why?
Systole
1
2021
171
0.050
Why?
Fluorescence
1
2001
148
0.050
Why?
Tight Junctions
1
2021
68
0.050
Why?
Microvessels
1
2021
68
0.050
Why?
Acetylation
1
2021
211
0.050
Why?
Genetic Predisposition to Disease
1
2009
2085
0.050
Why?
Nitric Oxide
1
2005
823
0.040
Why?
Receptors, Purinergic P2Y
1
2020
7
0.040
Why?
Cytokines
2
2021
1840
0.040
Why?
Ligands
1
2021
561
0.040
Why?
Neoplasms
1
2013
2097
0.040
Why?
GTPase-Activating Proteins
1
2019
71
0.040
Why?
Guanine Nucleotide Exchange Factors
1
2019
55
0.040
Why?
Trans-Activators
1
2001
367
0.040
Why?
Light
1
2001
336
0.040
Why?
Up-Regulation
1
2021
807
0.040
Why?
Oxygen
1
2002
854
0.040
Why?
Immune System
1
2019
172
0.040
Why?
Leukocytes
1
2019
276
0.040
Why?
Phosphatidylinositol 3-Kinases
1
2020
329
0.040
Why?
Middle Aged
5
2010
26732
0.040
Why?
Proto-Oncogene Proteins c-akt
1
2020
398
0.040
Why?
Adenosine Triphosphate
1
2020
430
0.040
Why?
Aorta
2
2001
386
0.040
Why?
Disease Susceptibility
1
2019
316
0.040
Why?
Culture Media, Serum-Free
1
1997
42
0.040
Why?
Proto-Oncogene Proteins c-sis
1
1997
35
0.040
Why?
Ischemia
1
2000
362
0.040
Why?
Protein Kinase C-alpha
1
1997
41
0.040
Why?
TOR Serine-Threonine Kinases
1
2020
358
0.040
Why?
Nuclear Proteins
1
2001
591
0.040
Why?
Sensitivity and Specificity
2
2001
1691
0.030
Why?
Organ Specificity
1
1997
268
0.030
Why?
Pregnancy, Animal
1
1997
52
0.030
Why?
Muscle Development
1
1997
98
0.030
Why?
Reactive Oxygen Species
1
2019
531
0.030
Why?
Bronchial Neoplasms
1
1996
14
0.030
Why?
Heart Ventricles
1
2021
712
0.030
Why?
Microcirculation
2
2007
135
0.030
Why?
Species Specificity
1
1997
542
0.030
Why?
Rabbits
1
1997
733
0.030
Why?
Point Mutation
1
1997
216
0.030
Why?
Blood Physiological Phenomena
1
1996
14
0.030
Why?
Dose-Response Relationship, Drug
2
2010
1842
0.030
Why?
Tritium
1
1996
66
0.030
Why?
Receptors, Platelet-Derived Growth Factor
1
1996
13
0.030
Why?
Neoplasms, Second Primary
1
1997
92
0.030
Why?
Exercise
1
2006
1644
0.030
Why?
Rats, Inbred Strains
1
1996
362
0.030
Why?
Myocytes, Cardiac
1
2019
449
0.030
Why?
Young Adult
1
2010
10465
0.030
Why?
DNA Mutational Analysis
1
1996
372
0.030
Why?
Quality of Life
1
2006
2353
0.030
Why?
Protein Precursors
1
1996
119
0.030
Why?
Clinical Trials as Topic
1
2019
931
0.030
Why?
Catalysis
1
1995
289
0.030
Why?
Models, Biological
1
2021
1620
0.030
Why?
Subcellular Fractions
1
1994
78
0.030
Why?
Flow Cytometry
2
1996
1083
0.030
Why?
Adenosine Diphosphate
1
1994
81
0.030
Why?
Recombinant Proteins
1
1997
1230
0.030
Why?
Stress, Mechanical
1
1996
445
0.030
Why?
Poly I-C
1
1994
51
0.030
Why?
Blood Proteins
1
1996
231
0.030
Why?
Risk Factors
5
2009
8631
0.030
Why?
Endothelin Receptor Antagonists
1
1993
58
0.030
Why?
Hyperplasia
2
2006
163
0.030
Why?
Neoplasm Proteins
1
1996
384
0.030
Why?
Receptors, Estrogen
1
1996
372
0.030
Why?
Extracellular Matrix
2
2006
436
0.030
Why?
Complement Factor B
1
1994
100
0.030
Why?
Serotonin
1
1994
292
0.030
Why?
Methylcholanthrene
1
2012
18
0.030
Why?
Adolescent
1
2010
17837
0.030
Why?
Pregnancy
3
2006
5517
0.030
Why?
Butylated Hydroxytoluene
1
2012
31
0.030
Why?
Time Factors
2
2007
6115
0.020
Why?
Immunoenzyme Techniques
1
2012
192
0.020
Why?
Peptides, Cyclic
1
1993
253
0.020
Why?
Infant, Newborn
2
2007
5044
0.020
Why?
Blood Platelets
1
1994
351
0.020
Why?
Apoptosis
1
2000
2362
0.020
Why?
Phorbol 12,13-Dibutyrate
1
1991
8
0.020
Why?
Cell Count
2
2006
303
0.020
Why?
Aerobiosis
1
1991
20
0.020
Why?
Anaerobiosis
1
1991
49
0.020
Why?
Dimethyl Sulfoxide
1
1991
43
0.020
Why?
Epithelial-Mesenchymal Transition
1
2012
167
0.020
Why?
Tumor Cells, Cultured
3
1996
849
0.020
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
225
0.020
Why?
Protein Binding
1
1996
1889
0.020
Why?
Chemoprevention
1
2010
88
0.020
Why?
Biopsy
2
2005
1036
0.020
Why?
DNA Replication
1
1991
202
0.020
Why?
Antioxidants
1
2012
530
0.020
Why?
RNA, Messenger
1
1996
2552
0.020
Why?
Down-Regulation
1
1990
594
0.020
Why?
Molecular Targeted Therapy
1
2010
347
0.020
Why?
Kinetics
1
1991
1551
0.020
Why?
Leukocyte Common Antigens
1
2007
75
0.020
Why?
Rats, Inbred WKY
1
2006
32
0.020
Why?
Elastin
1
2006
78
0.020
Why?
Proto-Oncogene Proteins c-kit
1
2006
63
0.020
Why?
Codon
2
1997
86
0.020
Why?
Aged, 80 and over
2
2009
6345
0.020
Why?
Serum
1
2006
57
0.020
Why?
PPAR gamma
1
2006
182
0.020
Why?
Vascular Resistance
1
2006
337
0.020
Why?
Chi-Square Distribution
1
2006
493
0.010
Why?
Protein Kinase Inhibitors
1
2010
785
0.010
Why?
Collagen
1
2006
415
0.010
Why?
Sheep
1
2006
764
0.010
Why?
Antibodies, Monoclonal
1
2010
1262
0.010
Why?
Adenocarcinoma
1
2010
795
0.010
Why?
Neoplasm Recurrence, Local
1
2009
858
0.010
Why?
Teaching
1
2006
213
0.010
Why?
Polymerase Chain Reaction
2
1997
993
0.010
Why?
Neoplasm Invasiveness
1
2005
442
0.010
Why?
Epithelial Cells
2
2001
950
0.010
Why?
Vital Capacity
1
2004
255
0.010
Why?
Confidence Intervals
1
2004
305
0.010
Why?
Activities of Daily Living
1
2006
349
0.010
Why?
Gestational Age
1
2006
760
0.010
Why?
Bronchopulmonary Dysplasia
1
2007
329
0.010
Why?
Forced Expiratory Volume
1
2004
475
0.010
Why?
Base Sequence
1
2006
2114
0.010
Why?
Patient Compliance
1
2006
525
0.010
Why?
CREB-Binding Protein
1
2001
27
0.010
Why?
Metaplasia
1
2001
54
0.010
Why?
Adaptation, Psychological
1
2006
547
0.010
Why?
Single-Blind Method
1
2001
258
0.010
Why?
Fluorescent Antibody Technique
1
2001
397
0.010
Why?
Chromosomes, Human, Pair 3
1
2000
49
0.010
Why?
Loss of Heterozygosity
1
2000
40
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
57
0.010
Why?
Carcinoma
1
2001
198
0.010
Why?
Ki-67 Antigen
1
2000
103
0.010
Why?
Fibrosis
1
2002
453
0.010
Why?
Airway Obstruction
1
2001
168
0.010
Why?
Prevalence
1
2005
2250
0.010
Why?
Risk
1
2001
812
0.010
Why?
Carcinoma, Non-Small-Cell Lung
2
1997
961
0.010
Why?
Cell Death
1
2000
322
0.010
Why?
Mitotic Index
1
1997
26
0.010
Why?
Bromodeoxyuridine
1
1997
72
0.010
Why?
Cytoskeletal Proteins
1
1997
145
0.010
Why?
Mammals
1
1999
244
0.010
Why?
Tunica Intima
1
1997
78
0.010
Why?
Myosins
1
1997
126
0.010
Why?
Comorbidity
1
2001
1448
0.010
Why?
Chromosome Banding
1
1996
21
0.010
Why?
Ovariectomy
1
1997
116
0.010
Why?
Ploidies
1
1996
17
0.010
Why?
Karyotyping
1
1996
102
0.010
Why?
Ligases
1
1996
30
0.010
Why?
Tumor Suppressor Protein p53
1
2000
445
0.010
Why?
Heparin
1
1997
224
0.010
Why?
Bronchoalveolar Lavage
1
1996
84
0.010
Why?
Immunohistochemistry
1
2000
1629
0.010
Why?
Immunophenotyping
1
1996
274
0.010
Why?
Transcription, Genetic
1
2001
1313
0.010
Why?
Regional Blood Flow
1
1997
424
0.010
Why?
HeLa Cells
1
1996
562
0.010
Why?
Mass Screening
1
2001
1004
0.010
Why?
Adult
2
2009
30542
0.010
Why?
Surveys and Questionnaires
1
2006
4622
0.010
Why?
Epidermal Growth Factor
1
1994
161
0.010
Why?
Calcimycin
1
1994
47
0.010
Why?
Prognosis
1
2001
3327
0.010
Why?
Interferon-beta
1
1994
79
0.010
Why?
Neoplasm Staging
1
1997
1167
0.010
Why?
Mice, Inbred C3H
1
1994
239
0.010
Why?
Cell Survival
1
1996
1020
0.010
Why?
Macrophage Activation
1
1994
164
0.010
Why?
Analysis of Variance
1
1993
1226
0.010
Why?
Interferon-gamma
1
1994
719
0.010
Why?
Mutation
1
2000
3345
0.010
Why?
Peptides
1
1994
848
0.010
Why?
Tumor Necrosis Factor-alpha
1
1994
1139
0.000
Why?
Retrospective Studies
1
2005
12544
0.000
Why?
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)